14:01 EDT GeoVax sees Gedeptin technology as potentially applicable to any solid tumor
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOVX:
- GeoVax Labs Announces $6 Million Public Offering
- GeoVax’s EMA guidance provides clear pathway, says Alliance Global Partners
- Closing Bell Movers: Solar stocks fall on tax credit threat
- GeoVax Labs files to sell 6.15M common units
- GeoVax Labs receives favorable European regulatory guidance supporting GEO-MVA